AI still cannot develop effective vaccines or drugs on its own
Artificial intelligence has made progress in protein analysis and molecule design, but it has not yet shown it can develop effective drugs autonomously. Vertex Pharmaceuticals tested about 50 AI-specialized companies to analyze some 10,000 compounds and none of the proposals became a viable drug. Tools such as Google DeepMind's AlphaFold and companies like Insilico Medicine, Recursion Pharmaceuticals and Isomorphic Labs aim to cut timelines and costs, while scientists argue AI should complement, not replace, clinical experimentation.















